China National Accord Medicines Corporation Ltd. (SHE:000028)
China flag China · Delayed Price · Currency is CNY
24.53
+0.01 (0.04%)
May 8, 2026, 3:04 PM CST

SHE:000028 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
5,1797,8027,4096,5026,0165,126
Cash & Short-Term Investments
5,1797,8027,4096,5026,0165,126
Cash Growth
-6.54%5.32%13.94%8.08%17.37%-18.44%
Accounts Receivable
25,43622,93921,11820,23516,20217,701
Other Receivables
611.95132.22146.41265.5666.8587.26
Receivables
26,04823,07121,29420,53916,30617,855
Inventory
8,4748,1227,4067,9897,8367,622
Other Current Assets
607.21,2001,4671,3401,5501,246
Total Current Assets
40,30840,19637,57636,37031,70831,848
Property, Plant & Equipment
2,5582,6923,4793,7243,4073,494
Long-Term Investments
3,3463,2783,0802,9472,7992,658
Goodwill
1,6051,6051,8592,7472,7502,776
Other Intangible Assets
397.96406.69479.54615.59647.52669.93
Long-Term Accounts Receivable
-1.7212.9315.9113.6816.59
Long-Term Deferred Tax Assets
322.3308.72249.41220.48185.25129.74
Long-Term Deferred Charges
309.17335.23467.67526.58572.55633.98
Other Long-Term Assets
277.64273.09352.1404.42532.4557.38
Total Assets
49,12449,09647,55647,57142,61642,784
Accounts Payable
20,51820,51618,10017,95215,23316,718
Accrued Expenses
202.91666.7779.14760.58998.17753.2
Short-Term Debt
2,5222,8553,4222,9032,1332,490
Current Portion of Long-Term Debt
710.9--1745.14-
Current Portion of Leases
-740.45944.371,002867.85848.33
Current Income Taxes Payable
328.23171.63128.03205.9237.8178.87
Current Unearned Revenue
361.49387.21349.74456.3586.96450.59
Other Current Liabilities
1,253768.631,0791,041926.05939.8
Total Current Liabilities
25,89826,10524,80224,33821,02822,379
Long-Term Debt
----17.571.64
Long-Term Leases
862.2912.181,3711,4521,3271,375
Long-Term Unearned Revenue
67.7169.2869.4874.9780.9187.72
Pension & Post-Retirement Benefits
-0.610.710.770.861.2
Long-Term Deferred Tax Liabilities
89.5993.87114.5146.05156.48175.95
Other Long-Term Liabilities
293.98290.7441.99581.45560.3670.52
Total Liabilities
27,21127,47226,80026,59323,17124,761
Common Stock
556.57556.57556.57556.57428.13428.13
Additional Paid-In Capital
4,2684,2684,2614,2614,3574,372
Retained Earnings
14,07413,78612,85412,59011,33310,103
Comprehensive Income & Other
-0.28-0.28-1.457.877.9121.87
Total Common Equity
18,89718,61017,67017,41516,12614,925
Minority Interest
3,0153,0153,0863,5633,3193,097
Shareholders' Equity
21,91321,62420,75520,97819,44518,022
Total Liabilities & Equity
49,12449,09647,55647,57142,61642,784
Total Debt
4,0964,5075,7375,3744,3914,786
Net Cash (Debt)
1,0843,2951,6711,1291,626340.48
Net Cash Growth
-97.18%48.07%-30.58%377.51%-82.99%
Net Cash Per Share
1.955.922.992.032.920.61
Filing Date Shares Outstanding
552.81556.57556.57556.57556.57556.57
Total Common Shares Outstanding
552.81556.57556.57556.57556.57556.57
Working Capital
14,41114,09112,77412,03210,6819,469
Book Value Per Share
34.1833.4431.7531.2928.9726.82
Tangible Book Value
16,89516,59815,33114,05312,72811,479
Tangible Book Value Per Share
30.5629.8227.5525.2522.8720.63
Buildings
-806.56807.91741.11738.01725.86
Machinery
-1,4141,3961,2941,1321,027
Construction In Progress
-21.6612.635.4435.1749.85
Source: S&P Global Market Intelligence. Standard template. Financial Sources.